Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2005
12/22/2005CA2569686A1 Highly selective novel amidation method
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2569535A1 Dpp-iv inhibitors
12/22/2005CA2569534A1 Dpp-iv inhibitors
12/22/2005CA2568929A1 Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/22/2005CA2565262A1 Nutritional formulations
12/21/2005EP1607401A1 Novel aryl fructose-1,6-Bisphosphatase inhibitors
12/21/2005EP1607396A1 Bicyclic inhibitors of glycogen synthase kinase 3
12/21/2005EP1607386A1 Lipid metabolism improving agent
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606287A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606282A2 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606018A2 Use of thyroid-stimulating hormone to induce lipolysis
12/21/2005EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/21/2005EP1605963A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
12/21/2005EP1605957A1 The use of lupin conglutin for the treatment of type ii diabetes
12/21/2005EP1605954A1 A food-supplement composition suitable for promoting iron absorption
12/21/2005EP1605947A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
12/21/2005EP1605925A1 Treatment of type 1 diabetes with pde5 inhibitors
12/21/2005EP1605897A2 Polyethelene glycol link glp-1 compounds
12/21/2005EP1605895A2 Oral insulin therapies and protocol
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1450834B1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1027058B1 Disaccharide derivatives for treating hyperglycaemia
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005CN1711261A New imidazopyrdine derivatives, its preparation method and medicine composition containing same
12/21/2005CN1711260A Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1711084A Substituted 4-alkoxyoxazol derivatives as PPAR agonists
12/21/2005CN1709257A Composition for treating hyperlipemia
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232511C Process for preparing oxazolyl acetate derivative and its salts
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232291C Medicine for treating diabetes
12/21/2005CN1232279C Antilipemic Chinese medicine
12/21/2005CN1232277C Product containing extract of balsam pear and pumpkin possessing functions of reducing blood sugar
12/21/2005CN1232255C Diabetes remedies
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977270 Tocotrienolquinone cyclization product with an anti-hypercholesterol effect
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977249 molecular weight reduction of dextran by hydrolysis, hydrogenation, and oxidation; complexing with ferric oxy-hydroxide; narrow molecular weight distribution controlled by the ratio of hydrogenated/oxygenated groups; improved stability; anemia
12/20/2005CA2290966C Sertraline salts and sustained-release dosage forms of sertraline
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/16/2005CA2505103A1 Nutritional supplement for adults
12/16/2005CA2505043A1 Nutritional supplement for infants
12/15/2005WO2005118555A1 Dipeptidyl peptidase inhibitors
12/15/2005WO2005118547A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117855A1 Drug for prevention or treatment of diabetes
12/15/2005WO2005117853A1 Therapeutic agent for hyperlipemia and therapeutic agent for diabetes
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277691 Pravastatin pharmaceutical formulations and methods of their use
12/15/2005US20050277685 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
12/15/2005US20050277679 Antidiabetic agents; dietetics; hypoglycermic agents; stable, high melting crystalline material, suitable for bulk preparation and handling
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes
12/15/2005US20050277657 Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277619 Preventing type II diabetes and treating impaired glucose tolerance, insulin resistance, hyperlipidemia, atherosclerosis, ischemic injury, and hypercholesterolemia by administering a purine containing a phosphonate group, e.g., N9-neopentyl-2-methylthio-8-(2-(5-phosphono)furanyl)adenine;
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050274671 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/14/2005EP1604989A1 DPP-IV inhibitors
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604980A1 DPP-IV inhibitors
12/14/2005EP1604670A1 Supplemental food for recovery from hypoglycemic symptoms
12/14/2005EP1604665A1 C-kit kinase inhibitor
12/14/2005EP1604659A1 Tablet containing water-absorbing amino acid
12/14/2005EP1604651A1 Transdermal patches and methods for delivering testosterone
12/14/2005EP1603927A1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates
12/14/2005EP1603917A1 Immunomodulating heterocyclic compounds
12/14/2005EP1603912A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603908A1 Quinazoline derivatives as tgf-beta inhibitors
12/14/2005EP1603551A2 Use of omega-3-fatty acids in the treatment of diabetic patients
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 1298